Vanda Pharmaceuticals Inc.
TREATMENT OF SCHIZOPHRENIA
Last updated:
Abstract:
Aspects of the invention relate generally to the treatment of schizophrenia and to monitoring for specific adverse reactions.
Status:
Application
Type:
Utility
Filling date:
28 Jun 2021
Issue date:
21 Oct 2021